How much is the high-frequency chest-wall oscillation devices market worth, and how is it expected to expand?
The high-frequency chest-wall oscillation devices market size has grown strongly in recent years. It will grow from $2.47 billion in 2024 to $2.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing aging population, increasing awareness and diagnosis, increasing disposable income, and the rising prevalence of respiratory conditions.
The high-frequency chest-wall oscillation devices market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing the number of COPD patients, increasing awareness about the benefits of airway clearance therapy, growing R&D investment, growing awareness about the benefits of HFCWO devices, and rising geriatric population. Major trends in the forecast period include increase in research activities, adoption of wearable HFCWO devices, integration of smart technology, shift towards home healthcare and telehealth services, and growing focus on pediatric care.
Get Your Free Sample of The Global High-Frequency Chest-Wall Oscillation Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16703&type=smp
What are the top drivers to the rising demand in the high-frequency chest-wall oscillation devices market?
The rising prevalence of chronic obstructive pulmonary diseases is expected to propel the growth of the high-frequency chest wall oscillation (HFCWO) devices market going forward. Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. COPD cases are the result of smoking, environmental pollutants, genetic predisposition, and an aging population. High-frequency chest wall oscillation (HFCWO) devices aid in managing chronic obstructive pulmonary disease (COPD) by mobilizing and clearing mucus from the airways, reducing infection risks, enhancing lung function, and improving patient comfort. For instance, in March 2022, according to the Scottish Public Health Observatory, a Scotland-based public health agency, COPD rates began rising in 2021-22 as the effects of COVID-19 lessened. The rate among males rose from 83.2 to 97.6 cases per 100,000, while it increased from 72.6 to 97.3 among females. Therefore, the rising prevalence of chronic obstructive pulmonary diseases drives the growth of the high-frequency chest wall oscillation (HFCWO) devices market.
How is the high-frequency chest-wall oscillation devices market segmented?
The high-frequency chest-wall oscillation devices market covered in this report is segmented –
1) By Type: Afflovest, Vest Type, Smartvest, Respirtech
2) By Technology: Percussion, Compression, Vibration
3) By Patient Population: Pediatric, Adult, Geriatric
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Afflovest: Portable Afflovest Devices, Afflovest for Pediatric Use, Afflovest for Adult Use
2) By Vest Type: Pneumatic Vest Devices, Battery-Powered Vest Devices, Adjustable Pressure Vest Devices
3) By Smartvest: Smartvest with Bluetooth Connectivity, Smartvest With Smartphone App Integration, Smartvest with Adjustable Settings
4) By Respirtech: Respirtech In-Home Devices, Respirtech Portable Devices, Respirtech Therapy for Chronic Lung Diseases
Order your report now for swift delivery
Who are the top competitors in the high-frequency chest-wall oscillation devices market?
Major companies operating in the high-frequency chest-wall oscillation devices market are F. Hoffmann-La Roche AG, Medtronic plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Baxter International Inc., Medline Industries LP., Hill-Rom Holdings Inc., Teleflex Incorporated, Lincare Holdings Inc., Tactile Medical, Vapotherm Inc., Aerogen, Electromed Inc., Trudell Medical International, Monaghan Medical Corporation, Hayek Medical, Ventec Life Systems, Respinova Ltd., PARI Medical Holding GmbH, Drägerwerk AG & Co. KGaA
What significant trends should we anticipate in the high-frequency chest-wall oscillation devices market over the forecast period?
Major companies operating in the high-frequency chest wall oscillation (HFCWO) devices market are developing programmable air pulse generators to enhance treatment customization and patient comfort. Programmable air pulse generators deliver controlled air pulses at adjustable frequencies and intensities, aiming to mobilize mucus and improve airway clearance in patients with conditions like cystic fibrosis or bronchiectasis. For instance, in November 2023, Electromed Inc., a US-based airway clearance device company, launched the fifth-generation SmartVest clearway airway clearance system for treating respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other conditions that require airway clearance therapy. The SmartVest Clearway system uses HFCWO therapy, which delivers alternating air pulses into a vest garment that rapidly compresses and releases the chest wall. The system delivers alternating air pulses into a vest garment that rapidly compresses and releases the chest wall, oscillating airflow within the airways. The SmartVest Clearway is designed to provide therapeutic relief for patients with ineffective secretion clearance due to muscle weakness, inadequate cough, or impaired ventilation.
Which regional trends are influencing the high-frequency chest-wall oscillation devices market, and which area dominates the industry?
North America was the largest region in the high-frequency chest-wall oscillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-frequency chest-wall oscillation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The High-Frequency Chest-Wall Oscillation Devices Market Report 2025 Offer?
The high-frequency chest-wall oscillation devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
High-frequency chest-wall oscillation (HFCWO) devices refer to medical devices used for airway clearance therapy. These devices deliver external mechanical vibrations to the chest wall, which help to mobilize and clear mucus from the lungs.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16703
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
